Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[Usefulness of atenolol in the treatment of patients with chronic bronchitis or bronchial asthma].

Chazan R, Droszcz W, Doboszyńska A, Kowalski J, Barliński J.

Pol Arch Med Wewn. 1983 Jan;69(1):15-9. Polish. No abstract available.

PMID:
6889142
2.

[Atenolol in the treatment of patients with airway obstruction].

Chazan R.

Pol Merkur Lekarski. 1998 Feb;4(20):89-91. Review. Polish.

PMID:
9591440
3.

Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.

Groth S, Tønnesen P, Asted M, Dirksen H, Sørensen PG.

Eur J Clin Pharmacol. 1986;30(6):653-8. Erratum in: Eur J Clin Pharmacol 1987; 31(6):744.

PMID:
3533563
4.
5.

Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.

Löfdahl CG, Svedmyr N.

Eur J Respir Dis. 1981 Dec;62(6):396-404.

PMID:
6751838
6.

Effect of atenolol on ventilatory and cardiac function in asthma.

Vilsvik JS, Schaanning J.

Br Med J. 1976 Aug 21;2(6033):453-5.

7.

Evaluation of aerosols of prostaglandins E1 and E2 as bronchodilators.

Kawakami Y, Uchiyama K, Irie T, Murao M.

Eur J Clin Pharmacol. 1973 Aug;6(2):127-32. No abstract available.

PMID:
4588852
8.

Ventilatory effects of atenolol and bevantolol in asthma.

Lammers JW, Folgering HT, van Herwaarden CL.

Clin Pharmacol Ther. 1985 Oct;38(4):428-33.

PMID:
4042527
9.

[Effect of atenolol in chronic pulmonary patients with airway obstruction].

Vancrombreucq JC, Schandevyl W.

Lille Med. 1978 Aug-Sep;23(7):506-12. French. No abstract available.

PMID:
31524
10.

A trial of a new adrenergic beta-receptor blocker, ICI 66.082, in the treatment of hypertension.

Erikssen J, Jervell J.

Acta Med Scand. 1975 Jul-Aug;198(1-2):49-53.

PMID:
1166824
11.

Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.

Dorow P, Thalhofer S, Bethge H, Disselhoff G, Wagner G.

J Cardiovasc Pharmacol. 1990;16 Suppl 5:S36-44.

PMID:
11527135
12.

[The efficacy of theopek in bronchial asthma and chronic bronchitis].

Korzh OB.

Ter Arkh. 1990;62(3):82-4. Russian.

PMID:
2368005
13.

Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.

Philip-Joet F, Saadjian A, Bruguerolle B, Arnaud A.

Eur J Clin Pharmacol. 1986;30(1):13-6.

PMID:
2872059
15.

A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.

Lammers JW, Müller ME, Folgering HT, van Herwaarden CL.

Br J Clin Pharmacol. 1986 Nov;22(5):595-602.

16.

beta 1 Selectivity of drugs: quality of the drug or quality of the patient?

von Wichert P, Perkow I, Teufel W.

Respiration. 1980;39(6):301-6.

PMID:
6106963
17.

[Comparative study of penbutolol and atenolol in the therapy of essential hypertension].

Fallo F, Pisani G, Mantero F.

Clin Ter. 1988 Jun 30;125(6):425-30. Italian. No abstract available.

PMID:
2973948
18.

[Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)].

Cornudella R, Castellano A, Santafé G.

Rev Clin Esp. 1973 Jun 15;129(5):469-76. Spanish. No abstract available.

PMID:
4732991
19.

[Atenolol. Successful therapy of light forms of coronary disease using a beta blockader].

Degenring FH, Degenering FW.

ZFA (Stuttgart). 1978 Feb 10;54(4):237-42. German. No abstract available.

PMID:
414471
20.

Supplemental Content

Support Center